Citalopram Tablet, Film Coated
Product Images NDC 82009-107

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Citalopram (NDC 82009-107). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quallent Pharmaceuticals Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (10 mg (500 Tablets Bottle))

Label for Citalopram Tablets, USP 10 mg film-coated oral tablets, in a 500 tablets package. The label indicates prescription use only (Rx only) and mentions that the tablets contain citalopram hydrobromide equivalent to 10 mg citalopram base. Manufactured by Aurobindo Pharma Limited, India, for Quallent Pharmaceuticals Health LLC. Includes storage instructions and a barcode.*

FDA Label Image

Package Label-principal Display Panel (20 mg (500 Tablets Bottle))

Label for Citalopram Tablets USP 20 mg film-coated tablets, containing 500 tablets per bottle. The product is manufactured by Aurobindo Pharma Limited, India, and labeled for Quallent Pharmaceuticals Health LLC, Cayman Islands. The label includes dosage, storage instructions, and a barcode, with directions to dispense a medication guide separately.*

FDA Label Image

Package Label-principal Display Panel (40 mg (500 Tablets Bottle))

Label for Citalopram Tablets USP 40 mg film-coated tablets, supplied as 500 tablets per container. The label includes storage instructions, manufacturer details (Aurobindo Pharma Limited, India), and labeler (Quallent Pharmaceuticals Health LLC, Cayman Islands). It states the prescription-only status and contains barcode and coding area information.*

FDA Label Image

Chemical Structure (Citalopram Str)

Chemical structure diagram of Citalopram Hydrobromide, showing the molecular arrangement including aromatic rings, cyano, fluorine, and tertiary amine groups associated with this pharmaceutical compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.